出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年5月
Enteral Feeding Devices Market – Global Forecast To 2029
経腸栄養デバイス市場 : タイプ (チューブ、ポンプ、シリンジ、投与セット)、年齢層 (成人、小児)、用途 (腫瘍、胃腸疾患、神経疾患、糖尿病)、エンドユーザー (病院、在宅医療、ACS) – 2029年までの世界予測
Enteral Feeding Devices Market by Type (Tubes, Pump, Syringes, Administration Sets), Age Group (Adult, Pediatric), Application (Oncology, Gastrointestinal, & Neurological Disorders, Diabetes), End User (Hospital, Home Care, ACS) – Global Forecast to 2029
| ページ数 | 391 |
| 図表数 | 465 |
| 価格 | |
| シングルユーザライセンス | USD 4,950 |
| マルチユーザライセンス（5名） | USD 6,650 |
| コーポレートライセンス | USD 8,150 |
| エンタープライズサイトライセンス | USD 10,000 |
| 種別 | 英文調査報告書 |
[myphp file=”contact”] 出版社・価格・納期について
Report Overview
The global enteral feeding devices market is projected to reach USD 5.6 billion in 2029 from USD 4.0 billion in 2023, at a CAGR of 6.2% between 2023 and 2029.
世界の経腸栄養デバイス市場は、2023年から2029年までのCAGRが6.2%で、2023年の40億ドルから2029年には56億ドルに達すると予測されています。
The market is anticipated to grow as a result of development continuous advancements in medical devices. The growing number of elderly individuals with chronic illnesses creates a need for long-term nutritional support solutions, fueling demand for enteral feeding devices which is expected to drive the market growth.
Growing public awareness and acceptance of enteral feeding as a viable nutritional support option is expanding the potential patient pool which further contributes to market growth. On the other hand, stringent regulatory compliance and complexities in supply chain management are expected to limit market growth to a certain extent.
“Based on the application, the oncology segment is expected to grow by the highest CAGR in the enteral feeding devices market.”
Cancer treatments like chemotherapy, radiation, and surgery can significantly impact a patient’s ability to eat and absorb nutrients. Enteral feeding ensures they receive the necessary calories, proteins, vitamins, and minerals to maintain immune system function to fight infection and promote healing, reduce muscle wasting often associated with cancer and its treatment also support wound healing after surgery, a common aspect of cancer treatment which is expected to drive the market growth.
“The low profile tube segment in enterostomy feeding tubes segment is expected to grow with the highest CAGR in the enteral feeding devices market.”
Low-profile feeding tubes (LPTs) offer several advantages over traditional feeding tubes, particularly for patients requiring long-term enteral feeding. LPTs sit flush against the skin, making them less visible compared to traditional tubes that protrude from the abdomen. This can significantly improve a patient’s body image and self-confidence which is expected to drive the market growth.
“Based on the age group, adult segment is expected to grow by the highest CAGR in the enteral feeding devices market.
Enteral feeding ensures adults receive the essential calories, proteins, vitamins, and minerals they need to support their immune system and fight infection, promote healing after surgery or illness, maintain muscle mass, which is crucial for overall health and strength and improve recovery and tolerance of medical treatments like chemotherapy or radiationwhich which is expected to drive the enteral feeding devices market.
“Based on the end user, hospital segment is expected to grow by the highest CAGR in the enteral feeding devices market.
Enteral feeding tubes, particularly gastrostomy (G-tubes) placed directly in the stomach, are generally more comfortable than NG tubes (inserted through the nose). This can significantly improve a patient’s experience, especially during extended hospital stays which is expected to drive the enteral feeding devices market.
“North America to grow with the highest CAGR in the enteral feeding devices market during the forecast period.”
The The rise of chronic diseases, growing awareness of enteral feeding benefits, continuous technological advancements, and economic considerations are fueling the expansion of the enteral feeding device market in North America.
Europe was the second largest segment in the enteral feeding devices market in 2023. The Germany accounted for the larger share of the European enteral feeding devices market in 2023. The rising number of chronic diseases and and growing awareness regarding enteral feeding devices is expected to drive the market growth in Europen market.
A breakdown of the primary participants (supply-side) for the enteral feeding devices market referred to for this report is provided below:
- By Company Type: Tier 50%, Tier 35%, and Tier 15%
- By Designation: C-level–35%, Director Level–40%, and Others–25%
- By Region: North America–35%, Europe–20%, Asia Pacific–10%, Latin America- 20%, Middle East & Africa and GCC Countries- 15%.
Prominent players in the enteral feeding devices market Fresenius SE & Co. KGAA. (Germany), Cardinal Health, Inc. (US), Nestlé S.A. (Switzerland), Avanos Medical, Inc. (US), Danone S.A. (France), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Cook Medical (US), Moog Inc. (US), Boston Scientific Corporation (US), Baxter International Inc. (US), Vygon (France), and Other players in the enteral feeding devices market are Applied Medical Technology (US), Amsino International Inc. (US), Omex Medical Technology (India), Danumed Medizintechnik (Germany), Medline Industries, Inc. (US), Fuji Systems (Japan), Kentec Medical (US), Dynarex Corporation (US), Vesco Medical LLC (US), Medela AG (Switzerland), Alcor Scientific (US), and Romsons (India)
Research Coverage:
The report analyzes the enteral feeding devices market and aims at estimating the market size and future growth potential of this market based on various segments such as age group, application, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, product/service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall enteral feeding devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (benefits and cost-effectiveness of enteral over parenteral nutrition, shift from parenteral to enteral nutrition for patients, high incidence of preterm births and genetic disorders in pediatric and neonatal patients , rapid growth in geriatric population and age-related chronic diseases, increasing prevalence of dysphagia), restraints (complications associated with enteral feeding devices, lack of patient awareness), opportunities (high growth opportunities for market players in developing countries, growing demand for enteral feeding in the home care sector) and challenges (insufficient reimbursement policies for enteral nutrition therapy in developing countries, dearth of skilled professionals and endoscopy specialists)
• Market Penetration: It includes extensive information on product portfolios offered by the major players in the global enteral feeding devices market. The report includes various segments in market type, age group, application, end user and region
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global enteral feeding devices market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by type, age group, application, end user and region
• Market Diversification: Comprehensive information about newly launched product and services, expanding markets, current advancements, and investments in the global enteral feeding devices market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of product and services, and capacities of the major competitors in the global enteral feeding devices market.
Table of Contents
1 INTRODUCTION 48
1.1 STUDY OBJECTIVES 48
1.2 MARKET DEFINITION 49
1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY 49
1.3 MARKET SCOPE 50
1.3.1 MARKETS COVERED 50
FIGURE 1 ENTERAL FEEDING DEVICES MARKET SEGMENTATION 50
1.3.2 REGIONS COVERED 51
FIGURE 2 ENTERAL FEEDING DEVICES MARKET: REGIONAL SEGMENTATION 51
1.3.3 YEARS CONSIDERED 51
1.4 CURRENCY CONSIDERED 52
TABLE 1 STANDARD CURRENCY CONVERSION RATES 52
1.5 STAKEHOLDERS 52
1.6 SUMMARY OF CHANGES 53
1.7 RECESSION IMPACT 53
2 RESEARCH METHODOLOGY 54
2.1 RESEARCH DATA 54
2.1.1 SECONDARY DATA 55
2.1.1.1 Key data from secondary sources 56
FIGURE 5 SUPPLY- AND DEMAND-SIDE PARTICIPANTS 58
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 59
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 59
2.2 MARKET SIZE ESTIMATION 60
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 63
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 66
2.4 MARKET SHARE ANALYSIS 67
2.5 STUDY ASSUMPTIONS 67
2.6 RESEARCH LIMITATIONS 67
2.6.1 METHODOLOGY-RELATED LIMITATIONS 67
2.6.2 SCOPE-RELATED LIMITATIONS 67
2.7 RISK ASSESSMENT 68
TABLE 2 RISK ASSESSMENT ANALYSIS 68
3 EXECUTIVE SUMMARY 69
FIGURE 15 ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 69
FIGURE 16 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION) 70
FIGURE 17 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 70
FIGURE 18 ENTERAL FEEDING DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 71
FIGURE 19 GEOGRAPHIC SNAPSHOT OF ENTERAL FEEDING DEVICES MARKET 72
4 PREMIUM INSIGHTS 73
4.1 ENTERAL FEEDING DEVICES MARKET OVERVIEW 73
FIGURE 20 RISING INCIDENCE OF PRETERM BIRTHS TO DRIVE MARKET 73
4.2 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY TYPE AND COUNTRY (2023) 74
FIGURE 21 ENTERAL FEEDING TUBES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 74
4.3 ENTERAL FEEDING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 75
FIGURE 22 CHINA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 75
4.4 ENTERAL FEEDING DEVICES MARKET, BY REGION, 2022–2029 76
FIGURE 23 ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD 76
4.5 ENTERAL FEEDING DEVICES MARKET: DEVELOPED VS. EMERGING MARKETS 76
FIGURE 24 EMERGING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 76
5 MARKET OVERVIEW 77
5.1 INTRODUCTION 77
5.2 MARKET DYNAMICS 77
FIGURE 25 ENTERAL FEEDING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 77
5.2.1 DRIVERS 78
5.2.1.1 Benefits and cost-effectiveness of enteral nutrition 78
5.2.1.2 High incidence of preterm births and genetic disorders in pediatric and neonatal patients 78
TABLE 3 US: TOTAL NUMBER OF PRETERM BIRTHS, 2015–2021 78
FIGURE 26 ADOPTION OF ENTERAL FEEDING TUBES IN PATIENTS SUFFERING FROM PRADER–WILLIE SYNDROME (2024) 79
5.2.1.3 Rapid growth in geriatric population and age-related chronic diseases 79
TABLE 4 DIABETIC POPULATION, BY REGION, 2021 VS. 2030 VS. 2045 80
TABLE 5 GLOBAL CANCER INCIDENCE, 2015–2040 80
TABLE 6 US: GERIATRIC POPULATION, 2022–2050 (MILLION) 81
5.2.1.4 Increasing prevalence of dysphagia 81
5.2.2 RESTRAINTS 82
5.2.2.1 Complications associated with enteral feeding devices 82
TABLE 7 COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING DEVICES 82
5.2.2.2 Lack of patient awareness about feeding tubes 84
5.2.3 OPPORTUNITIES 84
5.2.3.1 High growth opportunities in emerging economies 84
5.2.3.2 Growing demand for enteral feeding in home care settings 85
5.2.4 CHALLENGES 86
5.2.4.1 Insufficient reimbursement policies in emerging economies 86
5.2.4.2 Dearth of endoscopy specialists 86
5.3 INDUSTRY TRENDS 87
5.3.1 GROWING USE OF SENSORS TO REDUCE NG TUBE COMPLICATIONS 87
5.3.2 INCREASING PREFERENCE FOR LOW-PROFILE TUBES 87
5.3.3 SHIFT OF HEALTHCARE SYSTEMS FROM HOSPITALS TO COMMUNITY SETTINGS 88
5.4 TECHNOLOGY ANALYSIS 88
5.4.1 KEY TECHNOLOGIES 88
5.4.1.1 Flow generation 89
5.4.1.2 Flow control 89
5.4.2 COMPLEMENTARY TECHNOLOGIES 89
5.4.2.1 Embedded software 89
5.4.2.2 Sensing technology 89
5.4.2.3 Feeding tube replacement technology 90
5.4.2.3.1 Electromagnetic sensor-based systems 90
5.4.2.3.2 Camera-based systems 90
5.4.2.3.3 Impedance sensor-based systems 90
5.4.3 ADJACENT TECHNOLOGIES 90
5.4.3.1 Nutritional formula development 91
5.4.3.2 Wireless connectivity 91
5.4.3.3 Model-based infusion pumps 91
5.5 VALUE CHAIN ANALYSIS 92
FIGURE 27 ENTERAL FEEDING DEVICES MARKET: VALUE CHAIN ANALYSIS 92
5.6 SUPPLY CHAIN ANALYSIS 93
FIGURE 28 ENTERAL FEEDING DEVICES MARKET: SUPPLY CHAIN ANALYSIS 94
5.7 PORTER’S FIVE FORCES ANALYSIS 94
TABLE 8 ENTERAL FEEDING DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 94
FIGURE 29 ENTERAL FEEDING DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 95
5.7.1 THREAT OF NEW ENTRANTS 95
5.7.2 THREAT OF SUBSTITUTES 96
5.7.3 BARGAINING POWER OF SUPPLIERS 96
5.7.4 BARGAINING POWER OF BUYERS 96
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 97
5.8 KEY STAKEHOLDERS AND BUYING CRITERIA 97
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 97
FIGURE 30 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 97
TABLE 9 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 98
5.8.2 KEY BUYING CRITERIA 98
FIGURE 31 KEY BUYING CRITERIA FOR TOP THREE END USERS 98
TABLE 10 KEY BUYING CRITERIA FOR TOP THREE END USERS 98
5.9 REGULATORY LANDSCAPE 99
5.9.1 REGULATORY ANALYSIS 99
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
5.10 PATENT ANALYSIS 102
5.10.1 PATENT PUBLICATION TRENDS FOR ENTERAL FEEDING DEVICES 102
FIGURE 32 NUMBER OF PATENT PUBLICATIONS (JANUARY 2013–DECEMBER 2023) 102
5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 103
FIGURE 33 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR CLINICAL NUTRITION PATENTS (JANUARY 2013–DECEMBER 2023) 103
FIGURE 34 TOP APPLICANT COUNTRIES/REGIONS FOR CLINICAL NUTRITION PATENTS (JANUARY 2013–DECEMBER 2023) 104
5.11 TRADE ANALYSIS 105
5.11.1 IMPORT AND EXPORT DATA FOR ENTERAL FEEDING DEVICES 106
TABLE 17 IMPORT AND EXPORT DATA FOR ENTERAL FEEDING DEVICES, BY COUNTRY 106
5.12 PRICING ANALYSIS 106
5.12.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 106
TABLE 18 AVERAGE SELLING PRICE OF ENTERAL FEEDING TUBES, BY KEY PLAYER, 2023 106
TABLE 19 AVERAGE SELLING PRICE OF ENTERAL FEEDING PUMPS AND ADMINISTRATION SETS, BY KEY PLAYER, 2023 107
5.12.2 AVERAGE SELLING PRICE TREND, BY REGION 107
TABLE 20 AVERAGE SELLING PRICE OF ENTERAL FEEDING DEVICES, BY REGION, 2021–2023 107
5.13 REIMBURSEMENT ANALYSIS 108
5.13.1 NORTH AMERICA 108
5.13.2 EUROPE 108
5.13.3 ASIA PACIFIC 108
5.14 KEY CONFERENCES AND EVENTS, 2024–2025 108
TABLE 21 ENTERAL FEEDING DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS 109
5.15 UNMET NEEDS/END-USER EXPECTATIONS 109
5.16 APPLICATION OF ARTIFICIAL INTELLIGENCE 110
5.17 ECOSYSTEM ANALYSIS 110
FIGURE 35 ENTERAL FEEDING DEVICES MARKET: ECOSYSTEM MAP 111
TABLE 22 ENTERAL FEEDING DEVICES MARKET: ROLE IN ECOSYSTEM 111
5.18 CASE STUDY ANALYSIS 112
5.18.1 CONTINUOUS INNOVATION IN ENTERAL FEEDING DEVICES MARKET 112
5.18.2 PRIORITIZATION OF PATIENT SAFETY 112
5.18.3 DESIGNING USER-FRIENDLY ENTERAL FEEDING PUMPS 113
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 113
FIGURE 36 ENTERAL FEEDING DEVICES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 113
5.20 ADJACENT MARKETS FOR ENTERAL FEEDING DEVICES MARKET 113
FIGURE 37 ADJACENT MARKETS FOR ENTERAL FEEDING DEVICES MARKET 114
5.21 INVESTMENT AND FUNDING SCENARIO 114
FIGURE 38 ENTERAL FEEDING DEVICES MARKET: INVESTMENT AND FUNDING SCENARIO, 2018–2022 (USD MILLION) 114
6 ENTERAL FEEDING DEVICES MARKET, BY TYPE 115
6.1 INTRODUCTION 116
TABLE 23 ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 116
6.2 ENTERAL FEEDING TUBES 116
TABLE 24 MAJOR BRANDS OF ENTERAL FEEDING TUBES AVAILABLE IN MARKET 117
TABLE 25 ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 118
TABLE 26 ENTERAL FEEDING TUBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 118
6.2.1 ENTEROSTOMY FEEDING TUBES 119
TABLE 27 MAJOR BRANDS OF ENTEROSTOMY FEEDING TUBES AVAILABLE IN MARKET 119
TABLE 28 ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 120
TABLE 29 ENTEROSTOMY FEEDING TUBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 121
6.2.1.1 Standard enterostomy feeding tubes 122
TABLE 30 STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 122
TABLE 31 STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 123
6.2.1.1.1 Standard gastrostomy tubes 123
6.2.1.1.1.1 Increasing incidence of neurological disorders and growing demand for PEG and PRG tubes to drive segment 123
TABLE 32 STANDARD GASTROSTOMY TUBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124
6.2.1.1.2 Standard jejunostomy tubes 125
6.2.1.1.2.1 Facility of minimally invasive procedure during jejunostomy tube placement to propel market growth 125
TABLE 33 STANDARD JEJUNOSTOMY TUBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126
6.2.1.1.3 Standard gastrojejunostomy tubes 126
6.2.1.1.3.1 Increasing number of patients with poor stomach function to fuel segment 126
TABLE 34 STANDARD GASTROJEJUNOSTOMY TUBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 127
6.2.1.2 Low-profile enterostomy feeding tubes 128
TABLE 35 LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 128
TABLE 36 LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 129
6.2.1.2.1 Low-profile gastrostomy tubes 129
6.2.1.2.1.1 Low-profile gastrostomy tubes to command largest market share 129
TABLE 37 LOW-PROFILE GASTROSTOMY TUBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 130
6.2.1.2.2 Low-profile jejunostomy tubes 131
6.2.1.2.2.1 Decreasing healthcare costs and reduced hospital stays to drive market 131
TABLE 38 LOW-PROFILE JEJUNOSTOMY TUBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 131
6.2.1.2.3 Low-profile gastrojejunostomy tubes 132
6.2.1.2.3.1 Increasing demand for button gastrojejunostomy tubes to fuel segment growth 132
TABLE 39 LOW-PROFILE GASTROJEJUNOSTOMY TUBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133
6.2.2 NASOENTERIC FEEDING TUBES 133
TABLE 40 MAJOR BRANDS OF NASOENTERIC FEEDING TUBES AVAILABLE IN MARKET 134
TABLE 41 NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 134
TABLE 42 NASOENTERIC FEEDING TUBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 135
6.2.2.1 Nasogastric feeding tubes 136
6.2.2.1.1 Increased need for short-term feeding with minimal tube replacement to augment segment growth 136
TABLE 43 NASOGASTRIC FEEDING TUBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137
6.2.2.2 Nasojejunal feeding tubes 137
6.2.2.2.1 Growing use for critically ill and postoperative patients in hospitals to aid market growth 137
TABLE 44 NASOJEJUNAL FEEDING TUBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138
6.2.2.3 Nasoduodenal feeding tubes 139
6.2.2.3.1 Rising focus on safe and cost-effective enteral feeding to propel market growth 139
TABLE 45 NASODUODENAL FEEDING TUBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140
6.2.3 OROENTERIC FEEDING TUBES 141
6.2.3.1 Increasing use in feeding preterm babies with lower breathing complications to drive market 141
TABLE 46 OROENTERIC FEEDING TUBES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
6.3 ENTERAL FEEDING PUMPS 142
6.3.1 RISING PRETERM BIRTHS AND INCREASING FOCUS ON HOME CARE TO DRIVE MARKET 142
TABLE 47 MAJOR BRANDS OF ENTERAL FEEDING PUMPS AVAILABLE IN MARKET 142
TABLE 48 ENTERAL FEEDING PUMPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 143
6.4 ADMINISTRATION SETS 143
6.4.1 INCREASING FOCUS ON PATIENT CARE AND PRODUCT SAFETY TO SUPPORT MARKET GROWTH 143
TABLE 49 MAJOR BRANDS OF ADMINISTRATION SETS AVAILABLE IN MARKET 144
TABLE 50 ADMINISTRATION SETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145
6.5 ENTERAL SYRINGES 145
6.5.1 GROWING RELIABILITY ON TUBE FEEDING IN CHILDREN TO SPUR MARKET GROWTH 145
TABLE 51 MAJOR BRANDS OF ENTERAL SYRINGES AVAILABLE IN MARKET 146
TABLE 52 ENTERAL SYRINGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 147
6.6 CONSUMABLES 148
6.6.1 RISING DEMAND FOR ENTERAL NUTRITION TO SUPPORT MARKET GROWTH 148
TABLE 53 MAJOR BRANDS OF CONSUMABLES AVAILABLE IN MARKET 148
TABLE 54 CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149
7 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP 150
7.1 INTRODUCTION 151
TABLE 55 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 151
7.2 ADULT PATIENTS 151
7.2.1 HIGH BURDEN OF CHRONIC DISEASES IN GERIATRIC POPULATION TO DRIVE MARKET 151
TABLE 56 ENTERAL FEEDING DEVICES MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 153
7.3 PEDIATRIC PATIENTS 154
7.3.1 INCREASING NUMBER OF PRETERM BIRTHS TO PROPEL MARKET 154
TABLE 57 ENTERAL FEEDING DEVICES MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION) 155
8 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION 156
8.1 INTRODUCTION 157
TABLE 58 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 157
8.2 ONCOLOGY 157
FIGURE 39 GLOBAL AGE-STANDARDIZED RATE OF CANCER IN BOTH SEXES, BY REGION (2022) 158
TABLE 59 ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 158
TABLE 60 ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 159
8.2.1 HEAD & NECK CANCERS 160
8.2.1.1 Increasing incidence of dysphagia in head & neck cancer survivors to drive market 160
TABLE 61 ESTIMATED NUMBER OF HEAD & NECK CANCER CASES, BY REGION, 2020–2040 160
TABLE 62 HEAD & NECK CANCERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161
8.2.2 STOMACH & GASTROINTESTINAL CANCERS 162
8.2.2.1 Malnutrition and poor prognosis in gastrointestinal cancer patients to support market growth 162
TABLE 63 ESTIMATED NUMBER OF STOMACH CANCER CASES, BY REGION, 2020–2040 162
TABLE 64 STOMACH & GASTROINTESTINAL CANCERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 163
8.2.3 LIVER CANCER 164
8.2.3.1 Decreased food intake and increased nutrient loss in hepatic cancer to aid segment growth 164
TABLE 65 ESTIMATED NUMBER OF LIVER CANCER CASES, BY REGION, 2020–2040 164
TABLE 66 LIVER CANCER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 165
8.2.4 PANCREATIC CANCER 166
8.2.4.1 Frequent occurrence of cachexia and need for nutrition supplementation to fuel market growth 166
TABLE 67 ESTIMATED NUMBER OF PANCREATIC CANCER CASES, BY REGION, 2020–2040 166
TABLE 68 PANCREATIC CANCER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 167
8.2.5 ESOPHAGEAL CANCER 168
8.2.5.1 Growing prevalence of esophageal cancer with low survival rates to propel market 168
TABLE 69 ESTIMATED NUMBER OF ESOPHAGEAL CANCER CASES, BY REGION, 2020–2040 168
TABLE 70 ESOPHAGEAL CANCER MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 169
8.2.6 OTHER CANCERS 169
TABLE 71 ESTIMATED NUMBER OF OTHER CANCER CASES, BY REGION, 2020–2040 170
TABLE 72 OTHER CANCERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 170
8.3 GASTROINTESTINAL DISEASES 171
8.3.1 INCREASING INCIDENCE OF IRRITABLE BOWEL SYNDROME AND INFLAMMATORY BOWEL DISEASE TO DRIVE MARKET 171
TABLE 73 LIST OF DIGESTIVE SYSTEM-RELATED DISEASES/DISORDERS 171
TABLE 74 ENTERAL FEEDING DEVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 172
8.4 NEUROLOGICAL DISORDERS 173
8.4.1 INCREASED NEED FOR CLINICAL NUTRITION THERAPIES TO BOOST MARKET GROWTH 173
TABLE 75 ENTERAL FEEDING DEVICES MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 174
8.5 DIABETES 175
8.5.1 NEED FOR CONTROLLED ADMINISTRATION OF MEDICATIONS TO AUGMENT MARKET GROWTH 175
TABLE 76 TOTAL NUMBER OF NEW DIABETES CASES, BY COUNTRY, 2022 175
TABLE 77 TOP 10 COUNTRIES WITH HIGHEST PROPORTION OF PATIENTS WITH TYPE 1 DIABETES (0–19 YEARS) 176
TABLE 78 ENTERAL FEEDING DEVICES MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION) 177
8.6 HYPERMETABOLISM 178
8.6.1 INCREASING INCIDENCE OF BURN INJURIES AND SEPSIS IN LOW- AND MIDDLE-INCOME COUNTRIES TO DRIVE MARKET 178
TABLE 79 ENTERAL FEEDING DEVICES MARKET FOR HYPERMETABOLISM, BY COUNTRY, 2022–2029 (USD MILLION) 179
8.7 OTHER APPLICATIONS 180
TABLE 80 ENTERAL FEEDING DEVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 181
9 ENTERAL FEEDING DEVICES MARKET, BY END USER 182
9.1 INTRODUCTION 183
TABLE 81 ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 183
9.2 HOSPITALS 183
9.2.1 GROWING DEMAND FOR ENTERAL FEEDING DEVICES IN INTENSIVE CARE UNITS TO DRIVE GROWTH 183
TABLE 82 ENTERAL FEEDING DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION) 185
9.3 HOME CARE SETTINGS 186
9.3.1 GROWING NEED FOR LONG-TERM CARE TO PROPEL MARKET GROWTH 186
TABLE 83 ENTERAL FEEDING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 187
9.4 AMBULATORY CARE SETTINGS 188
9.4.1 GROWING DEMAND FOR SPECIALTY CARE TO DRIVE EXPANSION OF OUTPATIENT CLINICS 188
TABLE 84 ENTERAL FEEDING DEVICES MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 189
10 ENTERAL FEEDING DEVICES MARKET, BY REGION 190
10.1 INTRODUCTION 191
FIGURE 40 ENTERAL FEEDING DEVICES MARKET: GEOGRAPHIC OPPORTUNITIES 191
TABLE 85 ENTERAL FEEDING DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 192
10.2 NORTH AMERICA 192
10.2.1 NORTH AMERICA: RECESSION IMPACT 193
FIGURE 41 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET SNAPSHOT 193
TABLE 86 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 194
TABLE 87 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 88 NORTH AMERICA: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 89 NORTH AMERICA: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 90 NORTH AMERICA: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 91 NORTH AMERICA: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 196
TABLE 92 NORTH AMERICA: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 196
TABLE 93 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 196
TABLE 94 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 197
TABLE 95 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 96 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 198
10.2.2 US 198
10.2.2.1 Presence of major players and providers of enteral feeding devices to drive growth 198
TABLE 97 US: KEY MACROINDICATORS 199
TABLE 98 US: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 199
TABLE 99 US: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 200
TABLE 100 US: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 200
TABLE 101 US: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 200
TABLE 102 US: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 103 US: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 104 US: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 201
TABLE 105 US: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 202
TABLE 106 US: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 202
TABLE 107 US: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 203
10.2.3 CANADA 203
10.2.3.1 Increasing incidence of chronic diseases such as diabetes and cancer to support market growth 203
TABLE 108 CANADA: KEY MACROINDICATORS 204
TABLE 109 CANADA: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 204
TABLE 110 CANADA: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 204
TABLE 111 CANADA: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 112 CANADA: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 205
TABLE 113 CANADA: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 206
TABLE 114 CANADA: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 206
TABLE 115 CANADA: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 206
TABLE 116 CANADA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 207
TABLE 117 CANADA: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 207
TABLE 118 CANADA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 208
10.3 EUROPE 208
10.3.1 EUROPE: RECESSION IMPACT 208
TABLE 119 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 209
TABLE 120 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 209
TABLE 121 EUROPE: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 210
TABLE 122 EUROPE: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 210
TABLE 123 EUROPE: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 210
TABLE 124 EUROPE: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 125 EUROPE: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 126 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 211
TABLE 127 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 212
TABLE 128 EUROPE: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 129 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 213
10.3.2 GERMANY 213
10.3.2.1 Germany to hold largest share of European enteral feeding devices market 213
TABLE 130 GERMANY: KEY MACROINDICATORS 214
TABLE 131 GERMANY: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 132 GERMANY: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 133 GERMANY: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 215
TABLE 134 GERMANY: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 215
TABLE 135 GERMANY: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 216
TABLE 136 GERMANY: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 216
TABLE 137 GERMANY: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 216
TABLE 138 GERMANY: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 217
TABLE 139 GERMANY: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 140 GERMANY: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 218
10.3.3 UK 218
10.3.3.1 Significant increase in prevalence of cancer and neurological disorders to aid market growth 218
TABLE 141 UK: KEY MACROINDICATORS 219
TABLE 142 UK: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 219
TABLE 143 UK: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 219
TABLE 144 UK: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 220
TABLE 145 UK: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 220
TABLE 146 UK: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 220
TABLE 147 UK: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 221
TABLE 148 UK: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 221
TABLE 149 UK: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 221
TABLE 150 UK: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 222
TABLE 151 UK: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 222
10.3.4 FRANCE 222
10.3.4.1 Presence of well-established healthcare system to boost market 222
TABLE 152 FRANCE: KEY MACROINDICATORS 223
TABLE 153 FRANCE: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 223
TABLE 154 FRANCE: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 155 FRANCE: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 156 FRANCE: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 157 FRANCE: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 225
TABLE 158 FRANCE: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 225
TABLE 159 FRANCE: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 225
TABLE 160 FRANCE: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 226
TABLE 161 FRANCE: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 226
TABLE 162 FRANCE: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 227
10.3.5 ITALY 227
10.3.5.1 Growing demand for cost-effective home care services to favor market growth 227
TABLE 163 ITALY: KEY MACROINDICATORS 228
TABLE 164 ITALY: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 228
TABLE 165 ITALY: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 228
TABLE 166 ITALY: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 167 ITALY: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 168 ITALY: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 229
TABLE 169 ITALY: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 170 ITALY: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 230
TABLE 171 ITALY: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 230
TABLE 172 ITALY: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 231
TABLE 173 ITALY: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 231
10.3.6 SWITZERLAND 231
10.3.6.1 Well-developed medical technology industry to support market growth 231
TABLE 174 SWITZERLAND: KEY MACROINDICATORS 232
TABLE 175 SWITZERLAND: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 232
TABLE 176 SWITZERLAND: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 233
TABLE 177 SWITZERLAND: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 233
TABLE 178 SWITZERLAND: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 233
TABLE 179 SWITZERLAND: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 234
TABLE 180 SWITZERLAND: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 234
TABLE 181 SWITZERLAND: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 234
TABLE 182 SWITZERLAND: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 235
TABLE 183 SWITZERLAND: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 235
TABLE 184 SWITZERLAND: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 236
10.3.7 SPAIN 236
10.3.7.1 Significant increase in patients opting for enteral nutrition to support market growth 236
TABLE 185 SPAIN: KEY MACROINDICATORS 237
TABLE 186 SPAIN: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 237
TABLE 187 SPAIN: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 237
TABLE 188 SPAIN: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 238
TABLE 189 SPAIN: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 238
TABLE 190 SPAIN: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 238
TABLE 191 SPAIN: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 239
TABLE 192 SPAIN: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 239
TABLE 193 SPAIN: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 239
TABLE 194 SPAIN: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 240
TABLE 195 SPAIN: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 240
10.3.8 BENELUX 240
10.3.8.1 Rising cases of cancer to drive market 240
TABLE 196 BENELUX: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 241
TABLE 197 BENELUX: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 241
TABLE 198 BENELUX: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 242
TABLE 199 BENELUX: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 242
TABLE 200 BENELUX: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 242
TABLE 201 BENELUX: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 243
TABLE 202 BENELUX: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 243
TABLE 203 BENELUX: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 243
TABLE 204 BENELUX: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 244
TABLE 205 BENELUX: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 244
10.3.9 REST OF EUROPE 244
TABLE 206 REST OF EUROPE: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 245
TABLE 207 REST OF EUROPE: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 245
TABLE 208 REST OF EUROPE: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 246
TABLE 209 REST OF EUROPE: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 246
TABLE 210 REST OF EUROPE: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 247
TABLE 211 REST OF EUROPE: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 247
TABLE 212 REST OF EUROPE: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 247
TABLE 213 REST OF EUROPE: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 248
TABLE 214 REST OF EUROPE: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 248
TABLE 215 REST OF EUROPE: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 249
10.4 ASIA PACIFIC 249
10.4.1 ASIA PACIFIC: RECESSION IMPACT 249
FIGURE 42 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET SNAPSHOT 250
TABLE 216 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 251
TABLE 217 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 251
TABLE 218 ASIA PACIFIC: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 252
TABLE 219 ASIA PACIFIC: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 252
TABLE 220 ASIA PACIFIC: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 252
TABLE 221 ASIA PACIFIC: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 253
TABLE 222 ASIA PACIFIC: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 253
TABLE 223 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 253
TABLE 224 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 254
TABLE 225 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 254
TABLE 226 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 255
10.4.2 JAPAN 255
10.4.2.1 Rising geriatric population to drive market growth 255
TABLE 227 JAPAN: KEY MACROINDICATORS 256
TABLE 228 JAPAN: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 256
TABLE 229 JAPAN: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 256
TABLE 230 JAPAN: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 257
TABLE 231 JAPAN: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 257
TABLE 232 JAPAN: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 258
TABLE 233 JAPAN: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 258
TABLE 234 JAPAN: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 258
TABLE 235 JAPAN: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 259
TABLE 236 JAPAN: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 259
TABLE 237 JAPAN: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 260
10.4.3 CHINA 260
10.4.3.1 Growing investments in healthcare infrastructure development to drive adoption of enteral feeding devices 260
TABLE 238 CHINA: KEY MACROINDICATORS 261
TABLE 239 CHINA: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 261
TABLE 240 CHINA: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 262
TABLE 241 CHINA: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 262
TABLE 242 CHINA: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 262
TABLE 243 CHINA: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 263
TABLE 244 CHINA: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 263
TABLE 245 CHINA: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 263
TABLE 246 CHINA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 264
TABLE 247 CHINA: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 264
TABLE 248 CHINA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 265
10.4.4 INDIA 265
10.4.4.1 Increasing incidence of preterm births and head & neck cancers to drive market 265
TABLE 249 INDIA: KEY MACROINDICATORS 266
TABLE 250 INDIA: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 266
TABLE 251 INDIA: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 266
TABLE 252 INDIA: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 267
TABLE 253 INDIA: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 267
TABLE 254 INDIA: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 268
TABLE 255 INDIA: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 268
TABLE 256 INDIA: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 268
TABLE 257 INDIA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 269
TABLE 258 INDIA: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 269
TABLE 259 INDIA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 270
10.4.5 AUSTRALIA 270
10.4.5.1 Increasing volume of patients to boost market growth 270
TABLE 260 AUSTRALIA: KEY MACROINDICATORS 270
TABLE 261 AUSTRALIA: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 271
TABLE 262 AUSTRALIA: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 271
TABLE 263 AUSTRALIA: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 271
TABLE 264 AUSTRALIA: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 272
TABLE 265 AUSTRALIA: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 272
TABLE 266 AUSTRALIA: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 273
TABLE 267 AUSTRALIA: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 273
TABLE 268 AUSTRALIA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 273
TABLE 269 AUSTRALIA: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 274
TABLE 270 AUSTRALIA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 274
10.4.6 SOUTHEAST ASIA 274
10.4.6.1 Growing healthcare spending and healthcare infrastructure development to drive market growth 274
FIGURE 43 PREVALENCE OF DIABETES IN SOUTHEAST ASIA (2020) 275
TABLE 271 ESTIMATED NUMBER OF CANCER CASES IN SOUTHEAST ASIAN COUNTRIES, 2020 VS. 2040 (THOUSAND) 275
TABLE 272 SOUTHEAST ASIA: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 276
TABLE 273 SOUTHEAST ASIA: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 276
TABLE 274 SOUTHEAST ASIA: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 276
TABLE 275 SOUTHEAST ASIA: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 277
TABLE 276 SOUTHEAST ASIA: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 277
TABLE 277 SOUTHEAST ASIA: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 278
TABLE 278 SOUTHEAST ASIA: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 278
TABLE 279 SOUTHEAST ASIA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 278
TABLE 280 SOUTHEAST ASIA: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 279
TABLE 281 SOUTHEAST ASIA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 279
10.4.7 REST OF ASIA PACIFIC 279
TABLE 282 REST OF ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 280
TABLE 283 REST OF ASIA PACIFIC: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 280
TABLE 284 REST OF ASIA PACIFIC: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 280
TABLE 285 REST OF ASIA PACIFIC: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 281
TABLE 286 REST OF ASIA PACIFIC: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 281
TABLE 287 REST OF ASIA PACIFIC: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 282
TABLE 288 REST OF ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 282
TABLE 289 REST OF ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 282
TABLE 290 REST OF ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 283
TABLE 291 REST OF ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 283
10.5 LATIN AMERICA 283
10.5.1 LATIN AMERICA: RECESSION IMPACT 284
TABLE 292 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 284
TABLE 293 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 285
TABLE 294 LATIN AMERICA: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 285
TABLE 295 LATIN AMERICA: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 285
TABLE 296 LATIN AMERICA: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 286
TABLE 297 LATIN AMERICA: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 286
TABLE 298 LATIN AMERICA: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 287
TABLE 299 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 287
TABLE 300 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 287
TABLE 301 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 288
TABLE 302 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 288
10.5.2 BRAZIL 288
10.5.2.1 Brazil to dominate enteral feeding devices market in Latin America 288
TABLE 303 BRAZIL: KEY MACROINDICATORS 289
TABLE 304 BRAZIL: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 289
TABLE 305 BRAZIL: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 290
TABLE 306 BRAZIL: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 290
TABLE 307 BRAZIL: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 290
TABLE 308 BRAZIL: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 291
TABLE 309 BRAZIL: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 291
TABLE 310 BRAZIL: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 291
TABLE 311 BRAZIL: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 292
TABLE 312 BRAZIL: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 292
TABLE 313 BRAZIL: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 293
10.5.3 MEXICO 293
10.5.3.1 Rising prevalence of chronic diseases to drive growth 293
TABLE 314 MEXICO: KEY MACROINDICATORS 294
TABLE 315 MEXICO: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 294
TABLE 316 MEXICO: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 294
TABLE 317 MEXICO: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 295
TABLE 318 MEXICO: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 295
TABLE 319 MEXICO: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 296
TABLE 320 MEXICO: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 296
TABLE 321 MEXICO: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 296
TABLE 322 MEXICO: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 297
TABLE 323 MEXICO: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 297
TABLE 324 MEXICO: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 298
10.5.4 REST OF LATIN AMERICA 298
TABLE 325 REST OF LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 299
TABLE 326 REST OF LATIN AMERICA: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 299
TABLE 327 REST OF LATIN AMERICA: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 299
TABLE 328 REST OF LATIN AMERICA: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 300
TABLE 329 REST OF LATIN AMERICA: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 300
TABLE 330 REST OF LATIN AMERICA: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 301
TABLE 331 REST OF LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 301
TABLE 332 REST OF LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 301
TABLE 333 REST OF LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 302
TABLE 334 REST OF LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 302
10.6 MIDDLE EAST & AFRICA 302
10.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND BETTER HEALTH INSURANCE PENETRATION TO SUPPORT MARKET GROWTH 302
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 303
TABLE 335 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 303
TABLE 336 MIDDLE EAST & AFRICA: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 304
TABLE 337 MIDDLE EAST & AFRICA: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 304
TABLE 338 MIDDLE EAST & AFRICA: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 304
TABLE 339 MIDDLE EAST & AFRICA: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 305
TABLE 340 MIDDLE EAST & AFRICA: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 305
TABLE 341 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 305
TABLE 342 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 306
TABLE 343 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 306
TABLE 344 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 307
10.7 GCC COUNTRIES 307
10.7.1 INCREASING DEMAND FOR HEALTH SERVICES TO BOOST MARKET 307
10.7.2 GCC COUNTRIES: RECESSION IMPACT 307
TABLE 345 GCC COUNTRIES: ENTERAL FEEDING DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 308
TABLE 346 GCC COUNTRIES: ENTERAL FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 308
TABLE 347 GCC COUNTRIES: ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 308
TABLE 348 GCC COUNTRIES: STANDARD ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 309
TABLE 349 GCC COUNTRIES: LOW-PROFILE ENTEROSTOMY FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 309
TABLE 350 GCC COUNTRIES: NASOENTERIC FEEDING TUBES MARKET, BY TYPE, 2022–2029 (USD MILLION) 310
TABLE 351 GCC COUNTRIES: ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 310
TABLE 352 GCC COUNTRIES: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 310
TABLE 353 GCC COUNTRIES: ENTERAL FEEDING DEVICES MARKET FOR ONCOLOGY, BY TYPE, 2022–2029 (USD MILLION) 311
TABLE 354 GCC COUNTRIES: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 311
11 COMPETITIVE LANDSCAPE 312
11.1 OVERVIEW 312
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 312
FIGURE 44 STRATEGIES ADOPTED BY KEY PLAYERS IN ENTERAL FEEDING DEVICES MARKET, JANUARY 2020–APRIL 2024 313
11.3 REVENUE SHARE ANALYSIS 314
FIGURE 45 REVENUE ANALYSIS OF TOP PLAYERS IN ENTERAL FEEDING DEVICES MARKET, 2019–2023 (USD MILLION) 314
11.4 MARKET SHARE ANALYSIS 314
FIGURE 46 ENTERAL FEEDING DEVICES MARKET SHARE, BY KEY PLAYER, 2023 315
FIGURE 47 NORTH AMERICA: ENTERAL FEEDING PUMPS MARKET SHARE, BY KEY PLAYER, 2023 315
FIGURE 48 EUROPE: ENTERAL FEEDING PUMPS MARKET SHARE, BY KEY PLAYER, 2023 316
FIGURE 49 ENTERAL FEEDING TUBES MARKET SHARE, BY KEY PLAYER, 2023 316
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 317
11.5.1 STARS 317
11.5.2 EMERGING LEADERS 318
11.5.3 PERVASIVE PLAYERS 318
11.5.4 PARTICIPANTS 318
FIGURE 50 ENTERAL FEEDING DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 319
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES 319
11.6.1 PROGRESSIVE COMPANIES 319
11.6.2 DYNAMIC COMPANIES 320
11.6.3 STARTING BLOCKS 320
11.6.4 RESPONSIVE COMPANIES 320
FIGURE 51 ENTERAL FEEDING DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 320
11.7 COMPETITIVE BENCHMARKING 321
TABLE 355 ENTERAL FEEDING DEVICES MARKET: DETAILED LIST OF STARTUPS/SMES 321
TABLE 356 ENTERAL FEEDING DEVICES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 322
11.8 COMPANY FOOTPRINT 322
11.8.1 OVERALL COMPANY FOOTPRINT 323
FIGURE 52 ENTERAL FEEDING DEVICES MARKET: OVERALL COMPANY FOOTPRINT 323
11.8.2 PRODUCT FOOTPRINT 324
TABLE 357 ENTERAL FEEDING DEVICES MARKET: PRODUCT FOOTPRINT 324
11.8.3 AGE GROUP FOOTPRINT 325
TABLE 358 ENTERAL FEEDING DEVICES MARKET: AGE GROUP FOOTPRINT 325
11.8.4 APPLICATION FOOTPRINT 326
TABLE 359 ENTERAL FEEDING DEVICES MARKET: APPLICATION FOOTPRINT 326
11.8.5 END-USER FOOTPRINT 327
TABLE 360 ENTERAL FEEDING DEVICES MARKET: END-USER FOOTPRINT 327
11.8.6 REGIONAL FOOTPRINT 328
TABLE 361 ENTERAL FEEDING DEVICES MARKET: REGIONAL FOOTPRINT 328
11.9 BRAND/PRODUCT COMPARATIVE ANALYSIS 329
FIGURE 53 ENTERAL FEEDING DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 329
11.9.1 FRESENIUS SE & CO. KGAA 330
11.9.2 BAXTER INTERNATIONAL INC. 330
11.9.3 NESTLÉ S.A. 330
11.9.4 CARDINAL HEALTH 330
11.9.5 AVANOS MEDICAL, INC. 330
11.9.6 B. BRAUN MELSUNGEN AG 330
11.10 R&D EXPENDITURE OF KEY PLAYERS 331
FIGURE 54 R&D EXPENDITURE OF KEY PLAYERS IN ENTERAL FEEDING DEVICES MARKET, 2021–2023 331
11.11 COMPETITIVE SCENARIO 331
11.11.1 PRODUCT LAUNCHES & APPROVALS 331
TABLE 362 ENTERAL FEEDING DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020–APRIL 2024 331
11.11.2 DEALS 332
TABLE 363 ENTERAL FEEDING DEVICES MARKET: DEALS, JANUARY 2020–APRIL 2024 332
11.11.3 EXPANSIONS 334
TABLE 364 ENTERAL FEEDING DEVICES MARKET: EXPANSIONS, JANUARY 2020–APRIL 2024 334
11.12 VALUATION AND FINANCIAL METRICS OF KEY ENTERAL FEEDING DEVICE VENDORS 335
FIGURE 55 VALUATION AND FINANCIAL METRICS OF KEY ENTERAL FEEDING DEVICE VENDORS 335
12 COMPANY PROFILES 336
12.1 KEY PLAYERS 336
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 FRESENIUS SE & CO. KGAA 336
TABLE 365 FRESENIUS SE & CO. KGAA: COMPANY OVERVIEW 336
FIGURE 56 FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT (2023) 337
TABLE 366 FRESENIUS SE & CO. KGAA: PRODUCTS OFFERED 338
TABLE 367 FRESENIUS SE & CO. KGAA: EXPANSIONS (JANUARY 2020–APRIL 2024) 338
TABLE 368 FRESENIUS SE & CO. KGAA: OTHER DEVELOPMENTS (JANUARY 2020–APRIL 2024) 339
12.1.2 CARDINAL HEALTH 341
TABLE 369 CARDINAL HEALTH: COMPANY OVERVIEW 341
FIGURE 57 CARDINAL HEALTH: COMPANY SNAPSHOT (2023) 342
TABLE 370 CARDINAL HEALTH: PRODUCTS OFFERED 342
TABLE 371 CARDINAL HEALTH: PRODUCT LAUNCHES (JANUARY 2020–APRIL 2024) 343
TABLE 372 CARDINAL HEALTH, INC: DEALS (JANUARY 2020–APRIL 2024) 344
12.1.3 NESTLÉ S.A. 346
TABLE 373 NESTLÉ S.A.: COMPANY OVERVIEW 346
FIGURE 58 NESTLÉ S.A.: COMPANY SNAPSHOT (2023) 347
TABLE 374 NESTLE S.A.: PRODUCTS OFFERED 347
12.1.4 AVANOS MEDICAL, INC. 350
TABLE 375 AVANOS MEDICAL, INC.: COMPANY OVERVIEW 350
FIGURE 59 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT (2023) 351
TABLE 376 AVANOS MEDICAL, INC.: PRODUCTS OFFERED 352
12.1.5 DANONE S.A. 356
TABLE 377 DANONE S.A.: COMPANY OVERVIEW 356
FIGURE 60 DANONE S.A.: COMPANY SNAPSHOT (2023) 357
TABLE 378 DANONE S.A.: PRODUCTS OFFERED 358
TABLE 379 DANONE S.A.: EXPANSIONS (JANUARY 2020–APRIL 2024) 359
12.1.6 BECTON, DICKINSON AND COMPANY 360
TABLE 380 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 360
FIGURE 61 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023) 361
TABLE 381 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 362
TABLE 382 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–APRIL 2024) 363
12.1.7 B. BRAUN MELSUNGEN AG 364
TABLE 383 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 364
FIGURE 62 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT 365
TABLE 384 B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED 366
12.1.8 CONMED CORPORATION 367
TABLE 385 CONMED CORPORATION: COMPANY OVERVIEW 367
FIGURE 63 CONMED CORPORATION: COMPANY SNAPSHOT (2023) 368
TABLE 386 CONMED CORPORATION: PRODUCTS OFFERED 368
12.1.9 COOK MEDICAL 369
TABLE 387 COOK MEDICAL: COMPANY OVERVIEW 369
TABLE 388 COOK MEDICAL: PRODUCTS OFFERED 369
12.1.10 MOOG, INC. 371
TABLE 389 MOOG, INC.: COMPANY OVERVIEW 371
FIGURE 64 MOOG, INC.: COMPANY SNAPSHOT (2023) 372
TABLE 390 MOOG, INC.: PRODUCTS OFFERED 373
12.1.11 BOSTON SCIENTIFIC CORPORATION 374
TABLE 391 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 374
FIGURE 65 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023) 375
TABLE 392 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 375
TABLE 393 BOSTON SCIENTIFIC CORPORATION: DEALS (JANUARY 2020–APRIL 2024) 376
12.1.12 BAXTER INTERNATIONAL INC. 377
TABLE 394 BAXTER INTERNATIONAL INC.: COMPANY OVERVIEW 377
FIGURE 66 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2023) 378
TABLE 395 BAXTER INTERNATIONAL INC: PRODUCTS OFFERED 379
TABLE 396 BAXTER INTERNATIONAL INC: DEALS (JANUARY 2020–APRIL 2024) 380
12.1.13 VYGON 381
TABLE 397 VYGON: COMPANY OVERVIEW 381
TABLE 398 VYGON: PRODUCTS OFFERED 381
TABLE 399 VYGON: DEALS (JANUARY 2020–APRIL 2024) 383
12.2 OTHER PLAYERS 384
12.2.1 APPLIED MEDICAL TECHNOLOGY, INC. 384
12.2.2 AMSINO INTERNATIONAL, INC. 386
12.2.3 OMEX MEDICAL TECHNOLOGY 387
12.2.4 DANUMED MEDIZINTECHNIK GMBH 388
12.2.5 MEDLINE INDUSTRIES, LP 389
12.2.6 FUJI SYSTEMS CORPORATION 391
12.2.7 KENTEC MEDICAL 392
12.2.8 DYNAREX CORPORATION 393
12.2.9 VESCO MEDICAL, LLC 394
12.2.10 MEDELA AG 395
12.2.11 ALCOR SCIENTIFIC 396
12.2.12 ROMSONS 397
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 398
13.1 DISCUSSION GUIDE 398
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 403
13.3 CUSTOMIZATION OPTIONS 405
13.4 RELATED REPORTS 405
13.5 AUTHOR DETAILS 406